Silo Pharma (SILO) Net Income (2018 - 2026)
Silo Pharma (SILO) posted Net Income of -$1.6 million for Q1 2026, down 86.85% sequentially from -$881530.0 in Q4 2025, and down 59.69% YoY from -$4.1 million in Q1 2025.
Silo Pharma (SILO) Net Income (2018 - 2026) Analysis & Trends
Silo Pharma has reported Net Income for 9 years, with the latest figure at -$1.6 million in Q1 2026.
- Quarterly Net Income fell 59.69% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.8 million (down 4.77% YoY) and the FY2025 annual result came in at -$3.1 million, up 20.15% from the prior year.
- Net Income fell to -$1.6 million in Q1 2026 per SILO's latest filing, from -$881530.0 in the prior quarter.
- Over five years, Net Income peaked at -$1163.0 in Q1 2022 and troughed at -$1.8 million in Q1 2023.
- A 5-year average of -$1.1 million and a median of -$1.0 million in 2023 frame the typical range for Net Income.
- The sharpest annual moves came in 2022 and 2023: Net Income jumped 98.26% in 2022, then plunged 155772.06% in 2023.
- Over 5 years, Net Income stood at -$1163.0 in 2022, then tumbled by 90319.26% to -$1.1 million in 2023, then plunged by 64.57% to -$1.7 million in 2024, then jumped by 49.06% to -$881530.0 in 2025, then tumbled by 86.85% to -$1.6 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$1.6 million, -$881530.0, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | -832,829.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -832,829.00 |
| Mar 31, 2026 | -1.65 Mn |
| Dec 31, 2025 | -881,530.00 |
| Sep 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -1.20 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Dec 31, 2024 | -1.73 Mn |
| Sep 30, 2024 | -928,814.00 |
| Jun 30, 2024 | -931,779.00 |
| Mar 31, 2024 | -801,667.00 |
| Dec 31, 2023 | -1.05 Mn |
| Sep 30, 2023 | -660,160.00 |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -1.81 Mn |
| Mar 31, 2022 | -1,163.00 |
| Dec 31, 2021 | 229,022.00 |
| Sep 30, 2021 | -87,319.00 |
| Jun 30, 2021 | -73,183.00 |
| Mar 31, 2021 | -66,967.00 |
| Dec 31, 2020 | -189,119.00 |